{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:10:25Z","timestamp":1793211025544,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.parkreldis.2023.105848","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T12:16:06Z","timestamp":1694088966000},"page":"105848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Atypical brain FDG-PET patterns increase the risk of long-term cognitive and motor progression in Parkinson's disease"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1206-4170","authenticated-orcid":false,"given":"Alberto","family":"Imarisio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2029-6606","authenticated-orcid":false,"given":"Andrea","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Premi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Paola","family":"Caminiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8809-0877","authenticated-orcid":false,"given":"Luca","family":"Presotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Zatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lupini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Turrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Paghera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Perani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0119-3639","authenticated-orcid":false,"given":"Alessandro","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2023.105848_bib1","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/brain\/awx118","article-title":"Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression","volume":"140","author":"Fereshtehnejad","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2023.105848_bib2","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/jnnp-2019-320846","article-title":"Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in \u03b1-synucleinopathies","volume":"90","author":"Pilotto","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2023.105848_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrneurol.2016.196","article-title":"Precision medicine for disease modification in Parkinson disease","volume":"13","author":"Espay","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105848_bib4","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1212\/WNL.0000000000005161","article-title":"Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease","volume":"90","author":"Pilotto","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2023.105848_bib5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2967\/jnumed.111.089946","article-title":"Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study","volume":"52","author":"Bohnen","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.parkreldis.2023.105848_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jns.2016.11.068","article-title":"Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease","volume":"372","author":"Baba","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2023.105848_bib7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp-2016-313918","article-title":"Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study","volume":"88","author":"Firbank","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2023.105848_bib8","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s00259-018-4085-1","article-title":"Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson's disease","volume":"45","author":"Blum","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.parkreldis.2023.105848_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157074","article-title":"Predicting cognitive decline in Parkinson's disease using FDG-PET\u2013based supervised learning","volume":"132","author":"Booth","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.parkreldis.2023.105848_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31653-6","article-title":"Machine learning identified an Alzheimer's disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson's disease dementia","volume":"8","author":"Katako","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.parkreldis.2023.105848_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2023.105848_bib12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/mds.20513","article-title":"Clinical characteristics in early Parkinson's disease in a central California population-based study","volume":"20","author":"Kang","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2023.105848_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/mdc3.12921","article-title":"Levodopa equivalent dose conversion factors: an updated proposal including opicapone and safinamide","volume":"7","author":"Schade","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2023.105848_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3233\/JAD-150610","article-title":"Vascular risk factors and cognition in Parkinson's disease","volume":"51","author":"Pilotto","year":"2016","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.parkreldis.2023.105848_bib15","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2023.105848_bib16","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2023.105848_bib17","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.21844","article-title":"Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force","volume":"22","author":"Dubois","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2023.105848_bib18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.parkreldis.2015.08.024","article-title":"Mild Cognitive Impairment in newly diagnosed Parkinson's disease: a longitudinal prospective study","volume":"21","author":"Santangelo","year":"2015","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.parkreldis.2023.105848_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2023.105848_bib20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria, Mov","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Disord"},{"key":"10.1016\/j.parkreldis.2023.105848_bib21","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The movement disorder society criteria for the diagnosis of multiple system atrophy","volume":"37","author":"Wenning","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2023.105848_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2023.105848_bib23","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2023.105848_bib24","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2023.105848_bib25","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s12021-014-9235-4","article-title":"A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia","volume":"12","author":"Della Rosa","year":"2014","journal-title":"Neuroinformatics"},{"key":"10.1016\/j.parkreldis.2023.105848_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/nimg.1998.0381","article-title":"Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping","volume":"9","author":"Signorini","year":"1999","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2023.105848_bib27","first-page":"445","article-title":"Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting","volume":"6","author":"Perani","year":"2014"},{"key":"10.1016\/j.parkreldis.2023.105848_bib28","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/mds.23291","article-title":"Typical cerebral metabolic patterns in neurodegenerative brain diseases","volume":"25","author":"Teune","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2023.105848_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13269","article-title":"Evaluation of an optimized [ 18 F]fluoro-deoxy-glucose positron emission tomography voxel-wise method to early support differential diagnosis in atypical Parkinsonian disorders","volume":"24","author":"Caminiti","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105848_bib30","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/mds.22444","article-title":"Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment","volume":"24","author":"Hosokai","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2023.105848_bib31","first-page":"167","article-title":"FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort","volume":"18","author":"Caminiti","year":"2018"},{"key":"10.1016\/j.parkreldis.2023.105848_bib32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.parkreldis.2009.01.003","article-title":"Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's disease","volume":"15","author":"Aybek","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2023.105848_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuroimage.2017.12.050","article-title":"A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging","volume":"190","author":"Zeighami","year":"2019","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2023.105848_bib34","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3233\/JPD-150583","article-title":"Hypometabolism in posterior and temporal areas of the brain is associated with cognitive decline in Parkinson's disease","volume":"5","author":"Tard","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2023.105848_bib35","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1002\/hbm.24311","article-title":"Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in 18 F\u2010FDG PET imaging","volume":"39","author":"Wu","year":"2018","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.parkreldis.2023.105848_bib36","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2023.105848_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.parkreldis.2023.105848_bib38","first-page":"1","article-title":"Dementia with Lewy bodies: impact of co\u2010pathologies and implications for clinical trial design","author":"Toledo","year":"2022","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.parkreldis.2023.105848_bib39","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","article-title":"Tau positron emission tomographic imaging in the Lewy body diseases","volume":"73","author":"Gomperts","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2023.105848_bib40","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1038\/s41598-018-23041-x","article-title":"18F-AV-1451 in Parkinson's disease with and without dementia and in dementia with Lewy bodies","volume":"8","author":"Smith","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.parkreldis.2023.105848_bib41","article-title":"Tau-PET imaging in Parkinson's disease: a systematic review and meta-analysis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105848_bib42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00259-019-04538-7","article-title":"Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer's disease to Parkinson's disease","volume":"47","author":"Choi","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.parkreldis.2023.105848_bib43","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.3233\/JPD-223489","article-title":"Mapping cholinergic synaptic loss in Parkinson's disease: an [18F]FEOBV PET case-control study","volume":"12","author":"Horsager","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2023.105848_bib44","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1038\/s41598-022-06663-0","article-title":"A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism","volume":"12","author":"Papathoma","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.parkreldis.2023.105848_bib45","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1007\/s00259-021-05302-6","article-title":"Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism","volume":"48","author":"Schindlbeck","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.parkreldis.2023.105848_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2023.103475","article-title":"Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in \u03b1-synucleinopathies","volume":"39","author":"Carli","year":"2023","journal-title":"NeuroImage. Clin."},{"key":"10.1016\/j.parkreldis.2023.105848_bib47","article-title":"Alzheimer's Disease Neuroimaging Initiative, Interceptor Project, FDG-PET markers of heterogeneity and different risk of progression in amnestic MCI","author":"Caminiti","year":"2023","journal-title":"Alzheimers. Dement."},{"key":"10.1016\/j.parkreldis.2023.105848_bib48","first-page":"20","article-title":"Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria, Alzheimers","volume":"11","author":"Caminiti","year":"2019","journal-title":"Respir. Ther."},{"key":"10.1016\/j.parkreldis.2023.105848_bib49","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1212\/WNL.0000000000003634","article-title":"Natural course of mild cognitive impairment in Parkinson disease","volume":"88","author":"Pedersen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2023.105848_bib50","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2023.105848_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105669","article-title":"Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism","volume":"167","author":"Molinet-Dronda","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2023.105848_bib52","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/brain\/awaa019","article-title":"Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction","volume":"143","author":"Ruppert","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2023.105848_bib53","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/mds.28654","article-title":"Dopaminergic and serotonergic degeneration and cortical [18 F]fluorodeoxyglucose positron emission tomography in de novo Parkinson's disease","volume":"36","author":"Orso","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2023.105848_bib54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","article-title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study","volume":"16","author":"Schrag","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2023.105848_bib55","article-title":"FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: a whole-brain multimodal imaging meta-analysis","volume":"21","author":"Albrecht","year":"2019"},{"key":"10.1016\/j.parkreldis.2023.105848_bib56","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/RLU.0000000000002148","article-title":"Clinical, dopaminergic, and metabolic correlations in Parkinson disease","volume":"43","author":"Liu","year":"2018","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.parkreldis.2023.105848_bib57","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/archneur.59.11.1724","article-title":"Predicting motor decline and disability in Parkinson disease","volume":"59","author":"Marras","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105848_bib58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/ene.12476","article-title":"Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study","volume":"22","author":"Reinoso","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105848_bib59","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","article-title":"New clinical subtypes of Parkinson disease and their longitudinal progression a prospective cohort comparison with other phenotypes","volume":"72","author":"Fereshtehnejad","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2023.105848_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neurobiolaging.2018.12.001","article-title":"Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI","volume":"76","author":"Massa","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2023.105848_bib61","doi-asserted-by":"crossref","first-page":"e378","DOI":"10.1212\/WNL.0000000000012228","article-title":"Parkinson disease-related brain metabolic patterns and neurodegeneration in isolated REM sleep behavior disorder","volume":"97","author":"Shin","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2023.105848_bib62","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/ene.14215","article-title":"In\u2010vivo signatures of neurodegeneration in isolated rapid eye movement sleep behaviour disorder","volume":"27","author":"Carli","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2023.105848_bib63","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/mds.29317","article-title":"Clinical diagnostic accuracy of Parkinson's disease: where do we stand?","volume":"38","author":"Virameteekul","year":"2023","journal-title":"Mov. Disord."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023009276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802023009276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:29:20Z","timestamp":1761179360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802023009276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":63,"alternative-id":["S1353802023009276"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105848","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical brain FDG-PET patterns increase the risk of long-term cognitive and motor progression in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105848"}}